LABORATORY CORPORATION OF AMERICA HOLDINGS (NYSE: LH)

LABORATORY CORPORATION OF AMERICA HOLDINGS

NYSE: LH (Labcorp Holdings Inc.)

Last update: 2 days ago, 12:53PM

235.78

-3.94 (-1.64%)

Add to watchlist

Previous Close	239.72
Open	239.20
Volume	478,313
Avg. Volume (3M)	594,389
Market Cap	19,734,786,048

Price / Earnings (TTM)	26.64
Price / Earnings (Forward)	14.01
Price / Sales	1.45
Price / Book	2.33

52 Weeks Range	191.97 (-18%) — 258.59 (9%)
Earnings Date	20 Apr 2025 - 24 Apr 2025
TTM Dividend Yield	1.22%

Market Trend

		Short Term	Medium Term
Industry	Diagnostics & Research (US)	Bearish	Bearish
	Diagnostics & Research (Global)	Bearish	Bearish
Stock	Labcorp Holdings Inc.	Bullish	Bullish

AIStockmoo Score

1.3

Analyst Consensus	5.0
Insider Activity	-3.0
Price Volatility	2.0
Technical Moving Averages	2.5
Technical Oscillators	0.0
Average	1.30

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
LH	20 B	1.22%	26.64	2.33
DGX	19 B	1.83%	21.73	2.80
DHR	134 B	0.61%	35.32	2.81
TMO	161 B	0.37%	25.85	3.28
A	29 B	0.95%	23.50	5.09
IQV	25 B	-	19.24	4.23

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Sector	Healthcare
Industry	Diagnostics & Research
Investment Style	Mid Value
% Held by Insiders	0.37%
% Held by Institutions	96.14%

Ownership

Name	Date	Shares Held
Meridiem Investment Management Ltd.	31 Dec 2024	1,211,314

52 Weeks Range	191.97 (-18%) — 258.59 (9%)
Price Target Range	250.00 (6%) — 300.00 (27%)
High	300.00 (Citigroup, 27.24%)	Buy
Median	278.00 (17.91%)
Low	250.00 (Barclays, 6.03%)	Hold
Average	277.17 (17.55%)
Total	4 Buy, 2 Hold
Avg. Price @ Call	158.38

Firm	Date	Target Price	Call	Price @ Call
Truist Securities	12 May 2025	290.00 (23.00%)	Buy	0.000
Truist Securities	11 Apr 2025	274.00 (16.21%)	Buy	221.46
Piper Sandler	06 May 2025	280.00 (18.75%)	Hold	0.000
Baird	30 Apr 2025	267.00 (13.24%)	Buy	228.54
Barclays	30 Apr 2025	250.00 (6.03%)	Hold	228.54
Barclays	10 Apr 2025	240.00 (1.79%)	Hold	218.61
Redburn Atlantic	02 Apr 2025	276.00 (17.06%)	Buy	236.37
Citigroup	04 Mar 2025	300.00 (27.24%)	Buy	256.81

No data within this time range.

Date	Type	Details
08 May 2025	Announcement	Labcorp to Webcast Its Annual Meeting of Shareholders May 15
29 Apr 2025	Announcement	Labcorp Announces 2025 First Quarter Results
23 Apr 2025	Announcement	Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
10 Apr 2025	Announcement	Labcorp Declares Quarterly Dividend
02 Apr 2025	Announcement	Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease
01 Apr 2025	Announcement	Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide
31 Mar 2025	Announcement	Labcorp to Announce First Quarter Financial Results on April 29, 2025
11 Mar 2025	Announcement	Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
24 Feb 2025	Announcement	Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors

TTM Dividend Yield	1.22%
3Y Average Dividend Yield	1.20%
Payout Ratio	32.58%
Expected Next Dividend Payment	Jun 2025

Ex Date	Announcement Date	Payment Date	Details
27 Feb 2025	08 Jan 2025	12 Mar 2025	0.72 Cash
26 Nov 2024	10 Oct 2024	13 Dec 2024	0.72 Cash
29 Aug 2024	25 Jul 2024	13 Sep 2024	0.72 Cash
24 May 2024	11 Apr 2024	12 Jun 2024	0.72 Cash
26 Feb 2024	12 Jan 2024	13 Mar 2024	0.72 Cash
07 Nov 2023	12 Oct 2023	12 Dec 2023	0.72 Cash
07 Aug 2023	13 Jul 2023	08 Sep 2023	0.72 Cash
17 May 2023	06 Apr 2023	08 Jun 2023	0.72 Cash
22 Feb 2023	12 Jan 2023	13 Mar 2023	0.72 Cash
16 Nov 2022	12 Oct 2022	09 Dec 2022	0.72 Cash
17 Aug 2022	14 Jul 2022	09 Sep 2022	0.72 Cash
18 May 2022	07 Apr 2022	09 Jun 2022	0.72 Cash
Show more

Annual Dividend Yield

Year	Annual Dividend ($)	Frequency/Year	Yield %
2025	0.720	1	0.31
2024	2.88	4	1.26
2023	2.88	4	1.27
2022	2.16	3	1.07

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2025	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	5.74%
Operating Margin (TTM)	6.93%
Diluted EPS (TTM)	8.83
Quarterly Revenue Growth (YOY)	9.80%
Quarterly Earnings Growth (YOY)	-7.60%

Total Debt/Equity (MRQ)	91.11%
Current Ratio (MRQ)	1.44
Operating Cash Flow (TTM)	1.59 B
Levered Free Cash Flow (TTM)	885.66 M

Return on Assets (TTM)	4.05%
Return on Equity (TTM)	9.36%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)